GeneNews Limited

(GEN:CA)

By |

Profile

GeneNews Ltd is a Canadian company which is focused on developing and commercializing proprietary molecular diagnostic tests for early detection of diseases and personalized health management, with a primary focus on cancer-related indications. The company develops a proprietary platform technology, the Sentinel Principle, to identify novel biomarkers from whole blood. The lead product of the company is ColonSentry which is a blood test to determine the patient's current risk of having colorectal cancer.

Contact Information

Website: www.genenews.com
Email: contact@genenews.com
Main Phone: +1 905 209-2030
Address: 445 Apple Creek Boulevard
Address 2: Suite 220
State: ON
City / Town: Markham
Country: CAN
Postal Code: L3R 9X7

Issuer Information

Exchange: TSX
CEO: James R. Howard-Tripp
Employees: 18
NAICS: In-Vitro Diagnostic Substance Manufacturing(325413)
$ 0.03 $ 0. (0.00%)
Last Price 0.03 Change $ 0. Change % 0.00 Tick N/A
Bid 0.025 Bid Size 356,000.00 Ask 0.03 Ask Size 204,000.00
Open 0.03 High 0.03 Low 0.03 Prev Close 0.03
Last Trade Volume 16,000 52 Wk Hi 0.24 52 Wk Low 0.025
Market Cap 4.3 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 143,588,177.00 EPS (TTM) -0.03 PE Ratio N/A Exchange TSX
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 3 3 3 3
Low Target Price Estimate 3 3 3 3
Mean Target Price Estimate 3 3 3 3
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 06/05/14 06/05/14 06/05/14 06/05/14
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1